This robotics startup raised $75 million to automate drug manufacturing. See the pitch deck.

Image for article This robotics startup raised $75 million to automate drug manufacturing. See the pitch deck.
News Source : Business Insider

News Summary

  • Multiply Labs raised $75 million in a Series B funding round.
  • The company builds robots for manufacturing complex drugs.
  • The round was led by NantWorks, a holding company founded by billionaire Patrick Soon-Shiong.
  • AstraZeneca is a Multiply customer, and Founders Fund is also an investor in the company.
  • "The only way to hit throughput, cost, and quality is with robotics," said CEO Fred Parietti.
  • "Someone has to make the drugs," he said.
Multiply Labs CEO Fred PariettiMultiply Labs Multiply Labs raised $75 million to automate drug manufacturing.Its robots make complex drugs like gene therapies and mRNA treatments.

Must read Articles